I. Rensink

A new principle for rapid immunoassay of proteins based on in situ precipitate-enhanced ellipsometry.

C. Hack, W. Hermens, L. Aarden, 1999, Biophysical journal.

Chromatin-Independent Binding of Serum Amyloid P Component to Apoptotic Cells

A. Familian, C. Hack, P. Hordijk, 2001, The Journal of Immunology.

Amyloid P Component to Apoptotic Cells Chromatin-Independent Binding of Serum

A. Familian, C. Hack, P. Hordijk, 2001 .

Complement Activation by Apoptotic Cells Occurs Predominantly via IgM and is Limited to Late Apoptotic (Secondary Necrotic) Cells

L. Aarden, I. Rensink, C. Ciurana, 2004, Autoimmunity.

A plasma nucleosome releasing factor (NRF) with serine protease activity is instrumental in removal of nucleosomes from secondary necrotic cells

L. Aarden, S. Zeerleder, H. te Velthuis, 2007, FEBS letters.

UvA-DARE ( Digital Academic Repository ) A new principle for rapid immunoassay of proteins based on in situ precipate-enhanced ellipsometry

C. Hack, W. Hermens, L. Aarden, 1999 .

Nucleosome‐releasing factor: a new role for factor VII‐activating protease (FSAP)

L. Aarden, H. Velthuis, S. Zeerleder, 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

ELISA to measure neutralizing capacity of anti-C1-inhibitor antibodies in plasma of angioedema patients.

D. Hamann, D. Wouters, S. Zeerleder, 2015, Journal of immunological methods.

Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity

M. de Boer, A. Voskuyl, I. Bultink, 2017, Molecular immunology.

Chimaeric anti‐interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose‐escalating study

I. Rensink, Van Zaanen, Lokhorst, 1998, British journal of haematology.